ema prac naion semaglutide very rare side effect 2025 GLP-1 Drug Can Cause Rare, Potentially Blinding Effect, Warns Meeting highlights from the Pharmacovigilance

Beyond the more common side effects, there are other potential risks to consider

We emphasize utilization of communication frameworks when discussing prognosis and making decisions on pursuing therapies such as palliative inotropes, left ventricular assist devices (LVADs), and heart transplant

Keep vials protected from light in their original carton

Torrent Pharma, an Ahmedabad-based drug maker, has taken an early lead in the semaglutide market with nearly 38% share within a month of launch, according to The Economic Times

Tirzepatide, on the other hand, is a dual GIP/GLP-1 receptor agonist, meaning it activates both the GLP-1 and GIP receptors, offering enhanced weight loss benefits by further regulating appetite, glucose metabolism, and energy balance